| Catherine Fermin Jimenez, FNP | |
|
1030 Commerce Creek Blvd, Cape Coral, FL 33909-6529 | |
| (239) 997-3081 | |
| Not Available |
| Full Name | Catherine Fermin Jimenez |
|---|---|
| Gender | Female |
| Speciality | General Practice |
| Location | 1030 Commerce Creek Blvd, Cape Coral, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447003348 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 1760590962 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Catherine Fermin Jimenez, FNP 1911 Ne 20th Pl, Cape Coral, FL 33909-4666 Ph: (239) 440-0612 | Catherine Fermin Jimenez, FNP 1030 Commerce Creek Blvd, Cape Coral, FL 33909-6529 Ph: (239) 997-3081 |
News Archive
Researchers at the Institute for Genome Sciences at the University of Maryland School of Medicine have been awarded a research program contract from the U.S. Food and Drug Administration (FDA) to sequence, assemble, and annotate a population of bacterial pathogens using two high-throughput sequencing (HTS) technologies in support of the expansion of a vetted public reference database.
Expression Analysis, a leading provider of genomic services for clinical trials and research, announced today it has received CLIA certification. This milestone comes as the company enters its tenth year of providing genomic expertise; something the company refers to as "Genomic Know-How.
BioSilta announces the release of the EnPresso Tablet Cultivation Set, a tabletised form of the patented EnBase technology. The EnBase technology is based on providing an enzymatic-controlled glucose supply in a fed-batch type manner, which allows an extended growth period and promotes higher final cell density.
Ten weeks of preventive supplementation with a natural form of vitamin E called tocotrienol in dogs that later had strokes reduced overall brain tissue damage, prevented loss of neural connections and helped sustain blood flow in the animals' brains, a new study shows.
ZIOPHARM Oncology, Inc. today announced the initiation of the pivotal Phase III clinical trial for palifosfamide in patients with front-line metastatic soft tissue sarcoma. The study, called PICASSO 3, is an international, randomized, double-blinded, placebo-controlled trial designed to enroll approximately 424 patients with metastatic soft tissue sarcoma who have never been treated with chemotherapy for metastatic disease.
› Verified 5 days ago
Dr. Adam P Hall, D.O. General Practice Medicare: Not Enrolled in Medicare Practice Location: 811 Del Prado Blvd S, Cape Coral, FL 33990 Phone: 239-302-2697 Fax: 239-302-2699 | |
Alejandro Trujillo Sr., MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 1411 Se 16th Pl, Cape Coral, FL 33990 Phone: 239-673-6516 Fax: 239-673-6536 | |
Dr. Manny J Hernandez, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 1255 1 Viscaya Parkway, Suite 103, Cape Coral, FL 33990 Phone: 239-573-6111 Fax: 239-573-9534 | |
Milton John Mckelvie, DVM General Practice Medicare: Not Enrolled in Medicare Practice Location: 2015 Del Prado Blvd S., Cape Coral, FL 33990 Phone: 239-574-6171 | |
Marc Yallof, D.O. General Practice Medicare: Accepting Medicare Assignments Practice Location: 1708 Cape Coral Pkwy W, Suite 2, Cape Coral, FL 33914 Phone: 239-333-3333 Fax: 239-333-3332 | |
Miss Jeannie Michelle Arana, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 1435 Se 8th Ter, Suite E, Cape Coral, FL 33990 Phone: 239-424-2757 Fax: 239-772-0186 |